Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age
Article in Vaccines (September 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Vaccines (September 2023)
Article in Vaccines (September 2023)
Article in BMC Infectious Diseases (April 2023)